Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 342RC | — |
patient received only the diluent portion; patient received only the diluent portion; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 51-year-old female patient who received MMR (Priorix) (batch number 342RC, expiry date 01-MAY-2025) for prophylaxis. On 13-MAR-2025, the patient received Priorix. On 13-MAR-2025, an unknown time after receiving Priorix, the patient experienced inappropriate preparation of medication (Verbatim: patient received only the diluent portion) and inappropriate dose of vaccine administered (Verbatim: patient received only the diluent portion). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 31-MAR-2025 The nurse reported that the two patients that likely received an incomplete Priorix dose, but they could not confirm which patient received only the diluent portion, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered The nurse thought they should revaccinate both patients but one of them will receive an extra dose. The nurse asked for information about a patient receiving an extra dose of Priorix or if they could check titers prior to revaccination and asked what was the recommendation in that situation. This case is linked with US2025038566, reported by same reporter.; Sender's Comments: US-GSK-US2025038566:Same reporter/Different Patient